Production and secretion of insulin by the pancreatic β-cell;Production et sécrétion de l'insuline par la cellule β pancréatique

EMC - Endocrinologie

Volumn 2, Issue 4, 2005, Pages 241-264

  Magnan, C ^a   Ktorza, A ^b  

^a CNRS   (France)

^b INSTITUT DE RECHERCHES SERVIER   (France)

Author keywords

Exocytosis; Glucose metabolism; Incretins; Loop of regulation; Nervous factors; Primary stimuli; Secondary stimuli

Indexed keywords

EID: 32544449351     PISSN: 17425653     EISSN: 17425653     Source Type: Journal    
DOI: 10.1016/j.emcend.2005.07.001     Document Type: Short Survey

References (77)

1. Brown H, Sanger F, Kitai R. The structure of pig and sheep insulins. Biochem J 1955;60:556-65.
2. Melloul D, Marshak S, Cerasi E. Regulation of insulin gene transcription. Diabetologia 2002;45:309-26.
3. Gerozissis K. Brain insulin: regulation, mechanisms of action and functions. Cell Mol Neurobiol 200;23:1-25.
4. Steiner DF, Chan SJ, Welsh JM, Kwok SC. Structure and evolution of the insulin gene. Annu Rev Genet 1985; 19: 463-84.
5. German M, Ashcroft S, Docherty K, Edlund H, Edlund T, Goodison S, et al. The insulin gene promoter, a simplified nomenclature. Diabetes 1995;44:1002-4.
6. Petersen HV, Serup P, Leonard J, Michelsen BK, Madsen OD. Transcriptional regulation of the human insulin gene Is dependent on the homeodomain protein STF1 /IPF1 acting through the CT boxes. Proc Natl Acad Sci USA 1994;91:10465-9.
7. Ohlsson H, Karlsson K, Edlund T. IPF1, a homeodomain-containing transactivator of the insulin gene. EMBO J 1993; 12:4251-9.
8. Read ML, Clark AR, Docherty K. The helix-loop-helix transcription factor USF binds to a regulatory sequence of the human insulin gene enhancer. Biochem J 1993;295:233-7.
9. Grill V, Cerasi E. Stimulation by D-glucose of cyclic adenosine 3′-5′-monophosphate accumulation and insulin release in isolated pancreatic islet of the rat. J Biol Chem 1974;249:4196-201.
10. Drucker DJ, Philippe J, Mojsov S, Chick WL, Habener JF. Glucagon like peptide I stimulates insulin gene expression and increases cyclic AMP levels In a rat islet cell line. Proc Natl Acad Sci USA 1987;84:3434-8.
11. Inada A, Someya Y, Yamada Y, Ihara Y, Kubota A, Ban N, et al. The cyclic AMP response element modulator family regulates the insulin gene transcription by interacting with transcription factor IID. J Biol Chem 1999;274:21095-103.
12. Peers B, Leonard J, Sharma S, Teitelman G, Montminy MR. Insulin expression in pancreatic islet cells relies on cooperative interactions between the helix loop helix factor E47 and the homeobox factor STF1. Mol Endocrinol 1994; 8:1798-806.
13. Serup P, Petersen HV, Pedersen EE, Edlund H, Leonard J, Petersen JS, et al. The homeodomain protein IPF1/STF1 is expressed in a subset of islet cells and promotes rat insulin 1 gene expression dependent on an intact E1 helix-loop-helix factor binding site. Biochem J 1995;310(Pt3):997-1003.
14. Peshavaria M, Henderson E, Sharma A, Wright CV, Stein R. Functional characterization of the transactivation properties of the PDX-1 homeodomain protein. Mol Cell Biol 1997; 17:3987-96.
15. Clark AR, Wilson ME, Leibiger I, Scott V, Docherty K. A silencer and an adjacent positive element interact to modulate the activity of the human insulin promoter. Eur J Biochem 1995;232:627-32.
16. Docherty K, Clark AR. Nutrient regulation of insulin gene expression. FASEB J 1994;8:20-7.
17. Melloul D, Ben-Neriah Y, Cerasi E. Glucose modulates the binding of an islet-specific factor to a conserved sequence within the rat I and the human insulin promoters. Proc Natl Sci Acad USA 1993;90:3865-9.
18. Ferrer J, Gomis R, Fernandez Alvarez J, Casamitjana R, Vilardell E. Signals derived from glucose metabolism are required for glucose regulation of pancreatic islet GLTU2 mRNA and protein. Diabetes 1993;42:1273-80.
19. Hussain MA, Habener JF. Glucagon like peptide 1 increases glucose-dependent activity of the homeoprotein IDX-1 transactivating domain in pancreatic beta-cells. Biochem Biophys Res Commun 2000;274:616-9.
20. Koranyi L, James DE, Kraegen EW, Permutt MA. Feedback inhibition of insulin gene expression by insulin. J Clin Invest 1992;89:432-6.
21. Wu H, MacFarlane WM, Tadayyon M, Arch JR, James RF, Docherty K. Insulin stimulates pancreatic-duodenal homeobox factor 1 (PDX1) DNA-binding activity and insulin promoter activity in pancreatic beta cells. Biochem J 1999;344(Pt3):813-8.
22. Leibiger B, Wahlander K, Berggren PO, Leibiger IB. Glucose-stimulated insulin biosynthesis depends on insulin-stimulated insulin gene transcription. J Biol Chem 2000;275:30153-6.
23. Seufert J, Kieffer TJ, Habener JF. Leptin inhibits insulin gene transcription and reverses hyperinsulinemia in leptin-deficient ob/ob mice. Proc Natl Acad Sci USA 1999;96: 674-9.
24. Roduit R, Thorens B. Inhibition of glucose-induced insulin secretion by long-term preexposure of pancreatic islets to leptin. FEBS Lett 1997;415:179-82.
25. Seufert J. Leptin effects on pancreatic beta-cell gene expression and function. Diabetes 2004;53(suppl1): S152-8.
26. Portha B. Signalisation intracellulaire et exocytose de l'insuline. MTE 2000;2:37-46.
27. Duman H, Forte JG. What is the role of SNARE proteins in membrane fusion? Am J Physiol Cell Physiol 2003;285: C237-C249.
28. Gerber SH, Sudhof TC. Molecular determinants of regulated exocytosis. Diabetes 2002;51(suppl1):S3-S11.
29. Ozaki N, Shibasaki T, Kashima Y, Miki T, Takahashi K, Ueno H, et al. cAMP-GEFII is a direct target of cAMP in regulated exocytosis. Nat Cell Biol 2000;2:805-11.
30. Grodky G. Secretion of insulin. Handbook of experimental pharmacology, Insulin 2. New York: Springer-Verlag; 1975.
31. Mercan D, Malaisse WJ. Pancreatic islet B-cell individual variability rather than subpopulation heterogeneity. Mol Cell Endocrinol 1996;118:163-71.
32. Van Schravendijk CF, Foriers A, Hooghe-Peters EL, Rogiers V, De Meyts P, Sodoyez JC, et al. Pancreatic hormone receptors on islet cells. Endocrinology 1985;117: 841-8.
33. Pipeleers DG, Schuit FC, Van Schravendjik FH, Van De Winkel M. Interplay of nutrients and hormones in the regulation of glucagon release. Endocrinology 1985;117: 817-23.
34. Bernard-Kargar C, Kassis N, Berthault MF, Pralong W, Ktorza A. Sialylated form of the neural cell adhesion molecule (NCAM): a new tool for the identification and sorting of beta-cell subpopulations with different functional activity. Diabetes 2001; 50(suppl1 ):S125-30.
35. Albisser AM, Leibel BS, Ewart TG, Davidovac Z, Botz CK, Zingg W. An artificial endocrine pancreas. Diabetes 1974; 23:389-96.
36. Pfeifer MA, Halter JB, Porte Jr. D. Insulin secretion in diabetes mellitus. Diabetes 1981;35:123-30.
37. Cerasi E, Luft R, Efendic S. Decreased sensitivity of the pancreatic beta cells to glucose in predlabetic and diabetic subjects. A glucose dose-response study. Diabetes 1972; 21:224-34.
38. Henquin JC. Pathways in β-cell stimulus secretion coupling as targets for therapeutic insulin secretagogues. Diabetes 2004;53(suppl3):S48-58.
39. Bataille D. Endosulfin: novel regulators of insulin secretion. Drug News Perspect 2000; 13:453-62.
40. Malaisse W. Physiology and pathology of the pancreatic B-cell glucose-sensor device. Diabetes, obesity and hyperlipidemia. Amsterdam: Elsevier; 1990.
41. Malaisse WJ, Malaisse-Lagae F, Sener A, Hellerstrom C. Participation of endogenous fatty acids in the secretory activity of the pancreatic B-cell. Biochem J 1985;227:995-1002.
42. 2+, cAMP, and phospholipid-derived messengers in coupling mechanisms of insulin secretion. Physiol Rev 1987;67:1185-248.
43. Maechler P, Wollheim CB. Mitochondrial signals in glucose-stimulated insulin secretion in the beta cell. J Physiol 2000;529(Pt1):49-56.
44. Aizawa T, Komatsu M, Asanuma N, Sato Y, Sharp GW. Glucose action 'beyond ionic events' in the pancreatic beta cell. Trends Pharmacol Sci 1998;19:496-9.
45. 2+ from a membrane store co-localized with pancreatic islet-cell plasma membrane. Biochem J 1988;253:67-72.
46. 2+ in insulin secreting cells and its regulation by isolated organelles. Experientia 1984;40:1052-60.
47. Helman A, Amira R, Nicolaïdis S, Assan R. Glucagon release Induced by ventrolateral hypothalamic stimulation In the rat. Endocrinology 1980;106:1612-9.
48. Cerasi E, Grill V. Potentiation of Insulin release by glucose in man. Acta Endocrinol (Copenh) 1975;79:483-501.
49. Kahn SE, Bergman RN, Schwartz MW, Taborsky Jr. GJ, Porte Jr. D. Short-term hyperglycemia and hyperinsulinemia Improve insulin action but do not alter glucose action In normal humans. Am J Physiol 1992;262(4Pt1):E518-E523.
50. Grill V, Adamson U, Cerasi E. Immediate and time-dependent effects of glucose on insulin release from rat pancreatic tissue. Evidence for different mechanisms of action. J Clin Invest 1978;61:1034-43.
51. Rutter GA. Nutrient-secretion coupling in the pancreatic islet beta-cell: recent advances. Mol Aspects Med 2001;22: 247-84.
52. Charollais A, Gjinovci A, Huarte J, Bauquis J, Nadal A, Martin F, et al. Junctional communication of pancreatic beta-cells contributes to the control of insulin secretion and glucose tolerance. J Clin Invest 2000; 106:235-43.
53. Caton D, Calabrese A, Mas C, Serre-Beinier V, Wonkam A, Meda P. Beta-cell crosstalk: a further dimension in the stimulus-secretion coupling of glucose-induced insulin secretion. Diabetes Metab 2002;28(6Pt2):S45-53.
54. Le Gurun S, Martin D, Formenton A, Maechler P, Caille D, Waeber G, et al. Connexin-36 contributes to control function of insulin-producing cells. J Biol Chem 2003;278: 37690-7.
55. Opara EC, Garfinkel M, Hubbard VS, Burch WM, Akwari OE. Effect of fatty acids on insulin release: role of chain length and degree of unsaturation. Am J Physiol 1994;266(4Pt1 ): E635-E639.
56. Stein DT, Stevenson BE, Chester MW, Basit M, Daniels MB, Turley SD, et al. The insulinotropic potency of fatty acids is Influenced profoundly by their chain length and degree of saturation. J Clin Invest 1997; 100:398-403.
57. McGarry JD. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 2002;51:7-18.
58. Deeney JT, Gromada J, Hoy M, Olsen HL, Rhodes CJ, Prentki M, et al. Acute stimulation with long chain acylCoA enhances exocytosis In insulin-secreting cells (HIT T-15 and NMRI beta-cells). J Biol Chem 2000;275:9363-8.
59. Hwang D, Rhee SH. Receptor-mediated signaling pathways: potential targets of modulation by dietary fatty acids. Am J Clin Nutr 1999;70:545-56.
60. Berthiaume L, Deichaite I, Peseckis S, Resh MD. Regulation of enzymatic activity by active site fatty acylation. A new role for long chain fatty acid acylation of proteins. J Biol Chem 1994;269:6498-505.
61. Dunphy JT, Linder ME. Signalling functions of protein palmitoylation. Biochim Biophys Acta 1998; 1436:245-61.
62. Itoh Y, Kawamata Y, Harada M, Kobayashi M, Fujii R, Fukusumi S, et al. Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40. Nature 2003;422:173-6.
63. Assan R, Marre M, Gormley P. The amino acids-induced secretion of glucagon. In: Lefebvre P, editor. Glucagon. Berlin: Springer Verlag; 1983. p. 19-39.
64. Thorens B. Incrétines, sécrétion d'insuline et diabète. Med/Sci 2003; 19:8-9.
65. Dimitriatis G, Cryer P, Gerich J. Prolonged hyperglycaemia during infusion of glucose and somatostatin Impairs pancreatic A and B-cell responses to decrements In plasma glucose in normal man. Diabetologia 1985;28:63-9.
66. Kahn FA, Goforth PB, Zhang M, Satin LS. Insulin activates ATP-sensltlve K+ channels in pancreatic beta-cells through a phosphatidylinositol 3-kinase-dependent pathway. Diabetes 2001;50:2192-8.
67. Leibiger IB, Leibiger B, Berggren PO. Insulin feedback action on pancreatic beta-cell function. FEBS Lett 2002; 532:1-6.
68. Dalle S, Fontes G, Lajoix AD, LeBrigand L, Gross R, Ribes G, et al. Miniglucagon (glucagon 19-29): a novel regulator of the pancreatic islet physiology. Diabetes 2002;51:406-12.
69. Sekine N, Wollhelm CB, Fujita T. GH signalling in pancreatic beta-cells. Endocr J 1998;45(suppl):S33-40.
70. Galsgaard ED, Gouilleux F, Groner B, Serup P, Nielsen JH, Billestrup N. Identification of a growth hormone-responsive STAT5-binding element In the rat insulin 1 gene. Mol Endocrinol 1996;10:652-60.
71. Rakatzi I, Mueller H, Ritzeler O, Tennagels N, Eckel J. Adiponectin counteracts cytokine- and fatty acid-induced apoptosis In the pancreatic beta-cell line INS-1. Diabetologia 2004;47:249-58.
72. Ahren B. Autonomic regulation of islet hormone secretion-implication for health and disease. Diabetologia 2000;43: 393-410.
73. Ahren B, Taborsky Jr. GJ, Porte Jr. D. Neuropeptidergic versus cholinergic and adrenergic regulation of Islet hormone secretion. Diabetologia 1986;29:827-36.
74. Arimura A, Shioda S. Pituitary adenylate cyclase activating polypeptide (PACAP) and Its receptors: neuroendocrine and endocrine Interaction. Front Neuroendocrinol 1995; 16:53-88.
75. Chan S, Morgan N. Molecular analysis of a2-adrenoreceptor gene expression in rat pancreatic A and B-cells. Diabetologia 1995;38(suppl1):504.
76. Ahren B, Lindskog S. Galanin and the regulation of islet hormone secretion. Int J Pancreatol 1992;11:147-60.
77. Dunning B, Taborsky Jr. G. Galanin-sympathetic neurotransmitter in endocrine pancreas? Diabetes 1988;37:1157-62.